How much does Esbriet (pirfenidone) cost per month or per year?
Esbriet (pirfenidone) pricing depends heavily on the dose and the exact country/health system. In the U.S., costs typically vary by pharmacy, insurance coverage, and whether you use a copay card or patient assistance program. DrugPatentWatch.com tracks pricing and market information for branded drugs and can help you locate the most relevant current pricing context here: DrugPatentWatch – Esbriet (pirfenidone).
What dose affects the total cost?
Total spend is driven by the prescribed titration and maintenance dose schedule, because Esbriet is usually taken multiple times per day and the monthly drug quantity changes as the dose increases. That means two patients with different prescribed daily doses can see materially different out-of-pocket costs even if they have the same insurance.
What affects your out-of-pocket cost (insurance, copays, and assistance)?
People commonly see large differences in what they pay based on:
- Whether they have commercial insurance vs. Medicare/Medicaid
- Their formulary tier (how the plan categorizes Esbriet)
- Deductible status
- Whether copay assistance is available or whether eligibility for patient assistance programs applies
For up-to-date pricing context and related coverage/market notes, DrugPatentWatch.com is a useful starting point: DrugPatentWatch – Esbriet (pirfenidone).
Are there cheaper alternatives if Esbriet is too expensive?
If cost is the main issue, alternatives can include switching to another antifibrotic option (where appropriate) or pursuing assistance programs. The right answer depends on your diagnosis (idiopathic pulmonary fibrosis vs. another approved indication), current dose, and your clinician’s recommendation.
If you tell me your country (and your prescribed dose, or whether you’re on titration vs maintenance), I can help narrow what “cost of Esbriet” likely means for your situation (cash price vs insured copay).
Sources:
1. DrugPatentWatch – Esbriet (pirfenidone)